The $3.4 Billion Lesson Pharma Faces in Shelved Drugs
Thousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
Combining total market funds with international funds in retirement can create a diversified, tax-efficient portfolio with smoother growth.
28,507 articlesThousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
Beam Global is shaping the clean-energy charging space. In this piece, we break down what Q1 2026 earnings might reve...
California’s CEQA exemption is speeding residential projects, yet fault lines surface as opponents deploy new delay t...
Microsoft is recalibrating its internal AI tools as costs climb, signaling a broader shift in how AI is priced into b...
With the 2026 World Cup in North America on the horizon, per-player earnings from prize money could swing widely depe...
When a global star is spotted with a new rumored romance, the headlines aren't the only thing that shifts. This guide...
As the renewables wave grows, Clearway Energy (CWEN) stands out with a diversified solar and wind portfolio. This gui...
Rivian shocks investors by cutting jobs shortly after starting to deliver the R2. This move raises questions about ho...
Chasing Nvidia’s AI-driven rally is tempting, but utility stocks offer stable dividends, growth through grid moderniz...
Illinois embeds a first-of-its-kind 0.2% tax on digital asset activity in its $55.9 billion budget, set to take effec...
A fresh, no-copy analysis of Joint (JYNT) 2025 earnings, focusing on Q4 results, margin trends, and the roadmap for 2...
Warren Buffett has paused his annual gift to the Gates Foundation, signaling a shift in a years-long philanthropic pa...